Moxian, Inc. (MOXC) O2O Platform Connects Consumers, Businesses for ‘Online Lifestyle, Offline Fun’
Although it started mostly as a way for brick-and-mortar merchants to get more customers by offering special deals and discounts…
Blog
Net Element, Inc. (NETE) Reports 55% YOY Increase in Net Revenues for First Nine Months of 2016
Earlier today, Net Element, Inc. (NASDAQ: NETE) reported its financial results from the fiscal quarter and nine-month period ended September…
Singlepoint, Inc. (SING) Predicting Policy Changes for Newly-Expanded Marijuana Industry
Legalized cannabis, whether for recreational or medicinal purposes, is at the center of one of the nation’s most transformative industries.…
National Waste Management Holdings, Inc. (NWMH) Announces 269% Revenue Growth for Third Quarter
Before the opening bell, National Waste Management Holdings, Inc. (OTC: NWMH) announced its financial results for the three months ended…
GainClients, Inc. (GCLT) is “One to Watch”
GainClients, Inc. is a software service company focused primarily on the development of marketing services for real estate professionals and…
Singlepoint, Inc. (SING) CEO Reflects on Impact of Election Day Results on MoneyTV with Donald Baillargeon
Before the opening bell, Singlepoint, Inc. (OTC: SING) was announced as a featured company on this week’s episode of MoneyTV…
Achaogen, Inc. (AKAO) Attacks Super Bugs: Plazomicin Phase III Trials Are Underway
The era of the super bug is upon us, and Achaogen, Inc. (NASDAQ: AKAO) has joined the fray against them.…
Monaker Group (MKGI) – A Growing Presence in Alternative Lodging Rental Market
The alternative lodging rental market is maturing quickly, being one of the fastest growing verticals in the travel industry over…
Trevena, Inc. (TRVN) is “One to Watch”
Trevena, Inc. (NASDAQ: TRVN) is a clinical stage biopharmaceutical company focused on developing and delivering biased ligands to discover the…
Celldex Therapeutics, Inc. (CLDX) is “One to Watch”
Last month, Celldex Therapeutics, Inc. (NASDAQ: CLDX), a company in the business of developing targeted therapeutics for those suffering from…